Santos Sergio F F, Peixoto Aldo J
Division of Nephrology, State University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Clin J Am Soc Nephrol. 2008 Mar;3(2):522-30. doi: 10.2215/CJN.03360807. Epub 2008 Jan 16.
Hypertension and chronic volume overload are complications often seen in hemodialysis patients. Current hemodialysis practices adopt a standard dialysate sodium prescription that is typically higher than the plasma sodium concentration of most patients. As a general rule, hemodialysis patients have stable predialysis plasma sodium concentrations, and each patient has a fixed "osmolar set point." Hypertonic dialysate sodium prescriptions, including sodium modeling, predispose to positive sodium balance and lead to higher blood pressure and increased interdialytic weight gain. Conversely, lowering or individualizing dialysate sodium reduces thirst, interdialytic weight gain, and blood pressure in non-hypotension prone dialysis patients. Optimization of the dialysate sodium prescription is an important step in achieving sodium balance and improving blood pressure control in hypertensive hemodialysis patients.
高血压和慢性容量超负荷是血液透析患者常见的并发症。目前的血液透析操作采用标准透析液钠处方,其通常高于大多数患者的血浆钠浓度。一般来说,血液透析患者透析前血浆钠浓度稳定,且每个患者都有一个固定的“渗透设定点”。高渗透析液钠处方,包括钠模式化,易导致钠正平衡,并导致血压升高和透析间期体重增加。相反,降低或个体化透析液钠可减少非低血压倾向透析患者的口渴、透析间期体重增加和血压。优化透析液钠处方是实现钠平衡和改善高血压血液透析患者血压控制的重要一步。